MR1 Protein (AA 201-300) (GST tag)

N° du produit ABIN1311253

Détail du produit

Antigène: MR1 (Major Histocompatibility Complex, Class I-Related (MR1))

Type de proteíne: Recombinant

Attributs du protein: AA 201-300

Origine: Humain

Source: Wheat germ

Purification/Conjugué: Cette MR1 protéine est marqué à la GST tag.

Application: ELISA, Affinity Purification (AP), Antibody Array (AA), Western Blotting (WB)

Fonction: MR1 (Human) Recombinant Protein (Q01)

Séquence: TEPPLVRVNR KETFPGVTAL FCKAHGFYPP EIYMTWMKNG EEIVQEIDYG DILPSGDGTY QAWASIELDP QSSNLYSCHV EHCGVHMVLQ VPQESETIPL

Attributs du produit: Human MR1 partial ORF ( NP_001522, 201 a.a. - 300 a.a.) recombinant protein with GST-tag at N-terminal.

Purification: in vitro wheat germ expression system

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Preparation method: in vitro, wheat germ expression system
Product Quality tested by: 12.5% SDS-PAGE Stained with Coomassie Blue.

Restrictions: For Research Use only

Stockage

Buffer: 50 mM Tris-HCI, 10 mM reduced Glutathione, pH =8.0 in the elution buffer.

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: -80 °C

Stockage commentaire: Best use within three months from the date of receipt of this protein.

Détail du antigène

Antigène: MR1 (Major Histocompatibility Complex, Class I-Related (MR1))

Autre désignation: MR1 (MR1 Produits)

Synonymes: YFV Protein, hlals Protein, MGC154362 Protein, MR1 Protein, DKFZp468C1823 Protein, HLALS Protein, H2ls Protein, Hlals Protein, MHC class I antigen YF5 Protein, major histocompatibility complex, class I-related Protein, major histocompatibility complex, class I-related L homeolog Protein, YF5 Protein, MR1 Protein, mr1.L Protein, mr1 Protein, Mr1 Protein

Sujet: Full Gene Name: major histocompatibility complex, class I-related
Synonyms: HLALS

ID gène: 3140

NCBI Accession: NM_001531

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints